News
Food and Drug Administration Director Martin Makary announced the agency-wide deployment of an artificial intelligence tool ...
CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...
14h
Axios on MSNVinay Prasad believes that the FDA too often has acted as a rubber stamp for pharma, both big and small.Biotech venture capital is risky business, inherently at the mercy of regulators and binary outcomes. Now it may face a new ...
High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT ...
Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was ...
Cutting staff is quick way to lower your costs, but a haphazard approach like DOGE's could cost your company if you ...
OpenAI has reportedly met with officials from the Food and Drug Administration to discuss how AI could speed up drug ...
The US federal agency responsible for regulating medicines wants to speed up the evaluation process using the cderGPT ...
The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a ...
1d
India Today on MSNIndian-American doctor and anti-vaxxer picked to lead FDA's vaccines divisionIndian-origin hematologist-oncologist, Vinay Prasad, a vocal critic of Covid-19 norms like mask policies and booster shots, ...
A new report from Wired reveals the supposed ongoing discussions between the FDA and OpenAI that seeks to leverage AI for ...
ALBAWABA - The Food and Drug Administration (FDA), which is responsible for protecting public health by ensuring the safety, efficacy, and security of d ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results